BBM.CN stock down 50% to C$0.01 on 09 Mar 2026: thin liquidity raises valuation questions
BBM.CN stock plunged -50.00% to C$0.01 in market hours on 09 Mar 2026, signalling a sharp sell-off for Blueberries Medical Corp. (BBM.CN) on the CNQ exchange in Canada. The move followed heavy selling on a low-volume session with 15,000.00 shares traded versus an average of 13,251.00, and left the stock at its session low of C$0.01. Traders should weigh the decline against weak earnings per share and thin market depth before sizing positions.
BBM.CN stock: immediate price action and context
Blueberries Medical Corp. (BBM.CN) opened at C$0.02 and closed the market hours session at C$0.01, a -50.00% one-day move that cut the market cap to C$4,950,901.00. The intraday range was C$0.01 to C$0.02, with year high at C$0.03 and year low at C$0.01. This collapse occurred despite a modest free float and only 15,000.00 shares traded, underlining the role of low liquidity in amplifying price swings.
BBM.CN stock fundamentals and valuation
Fundamentals show small revenue per share at 0.00 and negative EPS of -0.01, producing a trailing PE of -1.00, which reflects loss-making status rather than a usable valuation multiple. Key ratios include a price to sales ratio of 11.96 and price to book of 6.46, both high for a micro-cap. Current ratio is 2.10, debt to equity is 0.01, and book value per share stands at 0.00, indicating limited tangible equity versus shares outstanding of 495,090,087.00. Investors should treat headline multiples cautiously given the tiny market cap and accounting scale.
BBM.CN stock: technicals, liquidity and trading risk
Technicals show short-term weakness: RSI at 38.31 and ADX 26.45 indicate a trending move with oversold momentum (CCI -259.26). Average price over 50 days sits near C$0.01, and 200-day average near C$0.02, so the current price is below recent longer-term averages. On-chain liquidity is thin: average volume 13,251.00 versus today’s 15,000.00; that relative depth means single orders can move price sharply and widen spreads on CNQ.
Meyka AI rates BBM.CN with a score out of 100 and model forecast
Meyka AI rates BBM.CN with a score out of 100: 67.65/100, grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not garantueed and we are not financial advisors. Meyka AI’s forecast model projects a yearly price of C$0.00747, compared with the current C$0.01, implying an expected downside of -25.33%. Forecasts are model-based projections and not guarantees.
BBM.CN stock risks, catalysts and sector context
Primary risks include continued low liquidity, negative EPS (-0.01) and high price-to-sales (11.96), which together raise dilution and financing risk for this small issuer. Catalysts that could stabilise the share include a clear operational update from management, stronger export or product contracts in Colombia, or improved sector flows into Healthcare micro-caps. The Healthcare sector in Canada has underperformed recently (6M performance -7.90%), so BBM.CN must outperform sector peers to attract capital.
News, peers and quick comparator links
Latest comparators and peer screens place BBM.CN among specialty and medicinal cannabis micro-caps. Use these investor tools to cross-check valuation and momentum: BBM comparison list on Investing.com and a related peer view including Medipharm Labs comparisons Investing.com peer screen. Review these alongside company releases before trading.
Final Thoughts
BBM.CN stock’s -50.00% drop to C$0.01 on 09 Mar 2026 highlights the fragility of micro-cap healthcare names on CNQ in Canada. Fundamentals show a loss-making business with EPS -0.01, a small market cap of C$4,950,901.00, and thin daily liquidity that amplifies volatility. Meyka AI rates the stock 67.65/100 (B, HOLD) after comparing sector and benchmark metrics and flags a modelled yearly price of C$0.00747, implying -25.33% from today’s price; this projection is a model output and not a guarantee. For traders, the near-term story is price discovery: validate any corporate news, monitor volume spikes, and treat position sizes conservatively given dilution and execution risk. For longer-term investors, improved revenue growth and clearer cash flow metrics will be required to justify higher multiples versus peers.
FAQs
Why did BBM.CN stock fall 50% today?
BBM.CN stock fell -50.00% on low liquidity and heavy selling; volume was 15,000.00 vs average 13,251.00, so modest orders caused a sharp price move on the CNQ exchange.
What are BBM.CN stock’s main valuation metrics?
Key metrics: EPS -0.01, PE -1.00, price to sales 11.96, price to book 6.46, market cap C$4,950,901.00; numbers reflect a tiny, loss-making micro-cap.
What does Meyka AI forecast for BBM.CN stock?
Meyka AI’s forecast model projects a yearly price of C$0.00747, implying -25.33% from the current C$0.01; forecasts are model-based projections and not guarantees.
Should investors buy BBM.CN stock after the drop?
Given thin liquidity, negative earnings, and small market cap, investors should be cautious; consider HOLD or small, highly managed exposure until clear operational progress emerges.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)